|
Gender
| |
0.313
| |
0.601
|
|
Male (n = 79)
|
53.4
| |
60.7
| |
|
Female (n = 57)
|
51.7
| |
66.7
| |
|
Age (years)
| |
0.643
| |
0.475
|
|
<65 (n = 95)
|
50.1
| |
59.7
| |
|
≥65 (n = 41)
|
56.8
| |
67.2
| |
|
Smoking status
| |
0.541
| |
0.312
|
|
Never (n = 103)
|
56.5
| |
70.6
| |
|
Former or current (n = 33)
|
46.5
| |
54.5
| |
|
Tumor size
| |
0.214
| |
0.295
|
|
>3 cm (n = 89)
|
46.7
| |
59.7
| |
|
≤3 cm (n = 43)
|
54.2
| |
66.2
| |
|
Adjuvant chemotherapy
| |
0.213
| |
0.713
|
|
Yes (n = 37)
|
59.1
| |
67.9
| |
|
No (n = 99)
|
49.0
| |
60.3
| |
|
Grade
| |
0.675
| |
0.233
|
|
Well (n = 57)
|
59.6
| |
73.3
| |
|
Moderate or poor (n = 79)
|
50.1
| |
55.4
| |
|
Pleural involvement
| |
0.769
| |
0.961
|
|
Yes (n = 69)
|
49.0
| |
60.4
| |
|
No (n = 67)
|
55.2
| |
67.5
| |
|
Lymphatic and/or vessel invasion
| |
0.045
| |
0.112
|
|
Yes (n = 12)
|
39.1
| |
51.7
| |
|
No (n = 124)
|
54.3
| |
68.1
| |
|
Histological subtypes (IASLC/ATS/ERS)
| | | | |
|
Lepidicpredominant
| |
0.042
| |
0.307
|
|
Yes (n = 21)
|
75.2
| |
80.8
| |
|
No (n = 115)
|
50.8
| |
59.3
| |
|
Acinarpredominant
| |
0.782
| |
0.443
|
|
Yes (n = 39)
|
55..5
| |
67.8
| |
|
No (n = 97)
|
49.0
| |
58.9
| |
|
Papillary predominant
| |
0.401
| |
0.405
|
|
Yes (n = 38)
|
57.6
| |
72.1
| |
|
No (n = 98)
|
47.1
| |
57.2
| |
|
Micropapillary predominant
| |
0.041
| |
0.175
|
|
Yes (n = 22)
|
28.4
| |
43.5
| |
|
No (n = 114)
|
61.1.
| |
62.9
| |
|
Solid predominant
| |
0.049
| |
0.211
|
|
Yes (n = 14)
|
36.7
| |
45.9
| |
|
No (n = 122)
|
57.7
| |
65.1
| |
|
Variants of invasive adenocarcinoma
|
0.315
| |
0.306
|
|
Yes (n = 2)
|
100
| |
100
| |
|
No (n = 134)
|
51.3
| |
60.5
| |
